Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

RENB

Renovaro Inc.

Jul 26 • 04:00PM ET

1.31

Dollar change +0.06
Percentage change 4.80	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VXF IWM IWO VTWO IWN IWC VTWG GERM RSSL

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.73	Insider Own	45.10%	Shs Outstand	147.50M	Perf Week	-2.96%
Market Cap	193.22M	Forward P/E	-	EPS next Y	-	Insider Trans	-0.70%	Shs Float	80.98M	Perf Month	-16.56%
Income	-53.93M	PEG	-	EPS next Q	-	Inst Own	4.98%	Short Float	4.65%	Perf Quarter	-22.94%
Sales	0.00M	P/S	-	EPS this Y	-	Inst Trans	-1.54%	Short Ratio	4.66	Perf Half Y	-73.13%
Book/sh	1.14	P/B	1.15	EPS next Y	-	ROA	-37.06%	Short Interest	3.76M	Perf Year	122.11%
Cash/sh	0.00	P/C	623.31	EPS next 5Y	-	ROE	-45.95%	52W Range	0.53 - 5.25	Perf YTD	-58.68%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-19.64%	ROI	-31.80%	52W High	-75.05%	Beta	0.64
Dividend TTM	-	Quick Ratio	0.06	Sales past 5Y	0.00%	Gross Margin	-	52W Low	147.17%	ATR (14)	0.15
Dividend Ex-Date	-	Current Ratio	0.06	EPS Y/Y TTM	63.31%	Oper. Margin	0.00%	RSI (14)	41.67	Volatility	8.69% 9.23%
Employees	12	Debt/Eq	0.05	Sales Y/Y TTM	-	Profit Margin	-	Recom	-	Target Price	-
Option/Short	Yes / Yes	LT Debt/Eq	0.01	EPS Q/Q	-104.92%	Payout	-	Rel Volume	0.29	Prev Close	1.25
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-	Earnings	-	Avg Volume	807.66K	Price	1.31
SMA20	-10.24%	SMA50	-6.11%	SMA200	-50.74%	Trades		Volume	233,303	Change	4.80%

Today 07:36AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
05:30AM	The Junk in Your Index Fund Is Costing You Big-Time (The Wall Street Journal)
Jun-14-24 09:06AM	Renovaro, Inc. Announces $10 million in Equity Committed (GlobeNewswire) +13.10%
May-24-24 09:20AM	Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy (GlobeNewswire) +7.58%
08:45AM	Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032 (GlobeNewswire)
08:53AM	Loading…
May-16-24 08:53AM	RENB Stock Earnings: Renovaro Biosciences Reported Results for Q3 2024 (InvestorPlace)
Apr-30-24 11:00AM	Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics (GlobeNewswire)
Apr-24-24 09:00AM	RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership (GlobeNewswire)
Apr-18-24 08:45AM	Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient Care (GlobeNewswire)
Mar-04-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Waldencast, Chemours, Trupanion, and Renovaro and Encourages Investors to Contact the Firm (GlobeNewswire) +12.99% -7.28%
Feb-15-24 09:25AM	Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace (GlobeNewswire) -8.68%
Feb-14-24 10:01AM	Statement of Renovaro Inc (GlobeNewswire) +14.06%
Feb-13-24 09:46AM	Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace (GlobeNewswire) -42.86%
09:31AM	AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine (GlobeNewswire)
Jan-25-24 12:45PM	Renovaro Biosciences Announces Results of Special Meeting of Shareholders (GlobeNewswire) +7.38%
09:30AM	Loading…
Jan-18-24 09:30AM	Renovaro BioSciences Releases CEO Shareholder Message (NewMediaWire)
Jan-16-24 08:00AM	Message from Renovaro Bioscience, Inc.'s CEO, The Hon. Mark Dybul, MD (GlobeNewswire)
Nov-28-23 08:30AM	Renovaro BioSciences CEO Featured in Recent Proactive Interview (NewMediaWire) -5.83%
Nov-23-23 09:30AM	Renovaro BioSciences Poised to Spearhead Advancements in Battle Against Diseases (NewMediaWire)
Nov-22-23 10:44AM	Renovaro Biosciences CEO unveils potential breakthrough therapies and AI partnerships for 2024 (News Direct)
Nov-21-23 08:30AM	Renovaro BioSciences Eyes Opportunity in Precision Medicine Market (NewMediaWire)
Nov-14-23 09:00AM	Renovaro Biosciences CEO Provides Update on Combination with GEDiCube (NewMediaWire)
Nov-10-23 08:30AM	Renovaro BioSciences, GEDi Cube Combine to Transform Medicine Through AI, Biotherapeutics (NewMediaWire) +5.38%
Nov-07-23 08:30AM	Renovaro Biosciences Adds Three New Members to Board as Definitive Agreement with GEDiCube Announced (NewMediaWire)
Oct-24-23 09:00AM	Renovaro BioSciences CEO Provides Insights on Agreement to Combine with GEDi Cube (NewMediaWire) -7.61%
Oct-11-23 09:25AM	Avram Miller, Co-Founder of Intel Capital, Joins Renovaro Biosciences Board of Directors (GlobeNewswire) -5.89%
08:30AM	Renovaro BioSciences Announces Board Appointments of Two Finance Experts (NewMediaWire)
Oct-10-23 08:00AM	Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors (GlobeNewswire) +19.08%
Oct-04-23 09:00AM	Renovaro BioSciences CEO Releases Shareholder Letter (NewMediaWire)
Oct-02-23 12:05PM	Message from Renovaro Biosciences CEO, The Hon. Mark Dybul, MD (GlobeNewswire) +5.15%
09:25AM	Loading…
09:25AM	AI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to Combine (GlobeNewswire)
08:30AM	Renovaro BioSciences Enters Definitive Agreement to Combine with Leading AI Tech GEDi Cube (NewMediaWire)
Sep-29-23 09:15AM	Renovaro Biosciences and AI Health Company GEDi Cube Sign Definitive Agreement to Combine (GlobeNewswire) +9.83%
09:15AM	GEDi Cube and Renovaro Biosciences Sign Definitive Agreement to Combine (Business Wire)
Sep-21-23 03:00PM	Renovaro BioSciences Targets Pancreatic Cancer Through Work With GEDI Cube AI Platform, NVIDIA Resources (NewMediaWire) +13.57%
Sep-19-23 08:30AM	Why Renovaro BioSciences Inc. Is 'One to Watch' (NewMediaWire)
Sep-06-23 12:40AM	Renovaro BioSciences Congratulates GEDiCube on New Joint Effort Clinical Trials (NewMediaWire) -6.98%
Aug-30-23 09:15AM	Renovaro BioSciences Welcomes GEDiCube Announcement of New Joint Effort (GlobeNewswire) +13.08%
Aug-21-23 09:15AM	Renovaro BioSciences Congratulates GEDi Cube on Appointment of its Chief Medical Officer (GlobeNewswire) +7.78%
Aug-10-23 12:06AM	Renovaro BioSciences, GEDi Cube Announce LOI to Merge, Focus on Fight Against Cancer (NewMediaWire)
Aug-09-23 09:00AM	AI Company GEDi Cube and Renovaro Biosciences Announce a Binding, Exclusive Letter of Intent to Merge, Accelerating Fight Against Cancer (GlobeNewswire) +82.35%
Jul-17-23 07:29AM	3 Doomed Biotech Stocks Destined for Disaster (InvestorPlace) +5.16%
Jun-23-23 05:00PM	Enochian BioSciences Inc. Announces Adjournment of 2023 Annual Stockholder Meeting (GlobeNewswire) -15.73% -13.37%
Jun-08-23 08:45AM	Enochian BioSciences Announces that its Cancer Platform Remains on Track for Trials in Humans Following FDA Review (GlobeNewswire) -6.31%
Apr-03-23 09:00AM	Enochian BioSciences CEO Letter to Shareholders (GlobeNewswire) +10.37%
Mar-29-23 09:00AM	Enochian BioSciences Announces a Scientific Presentation of Proof-of-Concept Studies for a Potential Therapy for Cancers with a Poor Life Expectancy by a Leading Researcher (GlobeNewswire)
Mar-13-23 08:30AM	Enochian BioSciences Achieves Full Compliance with NASDAQ Filing Requirements (GlobeNewswire) +6.54%
Feb-23-23 04:04PM	Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended December 31, 2022 (GlobeNewswire) +19.77%
Nov-30-22 05:20PM	Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended September 30, 2022 (GlobeNewswire) -22.26%
Oct-26-22 12:01AM	Corrections & Amplifications (The Wall Street Journal) -8.04%
Oct-24-22 08:11PM	Biotech Co-Founder, Facing Murder-for-Hire Charges, Accused of Fabricating Data (The Wall Street Journal) -7.11%
08:00AM	Enochian BioSciences Forges Ahead With Focused Approach, Promising Future (GlobeNewswire)
Oct-21-22 05:00PM	Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Annual Report on Form 10-K (GlobeNewswire)
Oct-17-22 08:30AM	Enochian BioSciences Awarded U.S. Patent For Its Promising Oncology Platform (GlobeNewswire) +7.34%
Sep-01-22 08:08AM	Enochian Biosciences, Inc. (NASDAQ:ENOB) insiders have significant skin in the game with 49% ownership (Simply Wall St.)
Jul-25-22 10:15AM	Enochian BioSciences Appoints Dr. Richard Whitley As Senior Scientific Advisor (GlobeNewswire) -10.50%
Jul-01-22 08:37PM	Enochian Biosciences Finds Falsified Data in Study of Covid-19 Treatment (The Wall Street Journal) +17.62%
05:00PM	Enochian BioSciences Announces Findings From A Rigorous Internal Review of Scientific Data (GlobeNewswire)
Jun-27-22 03:00PM	Biotech Wizard Left a Trail of FraudProsecutors Allege It Ended in Murder (The Wall Street Journal) -21.92%
Jun-10-22 04:00PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Enochian Biosciences (ENOB) Investors with Significant Losses to Contact Firms Attorneys, Firm Investigating Possible Securities Law Violations (ACCESSWIRE) +12.84% -8.20%
Jun-09-22 05:59PM	Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Enochian To Contact Him Directly To Discuss Their Options (ACCESSWIRE) -5.10%
May-31-22 08:00AM	Scientific Leaders Agree on Promise of Enochian BioSciences (GlobeNewswire)
May-25-22 04:20PM	Enochian BioSciences Board Learns of Arrest of Co-Founder and Inventor and Expresses Strong Confidence in the Promising Future of the Company (GlobeNewswire) -36.97% +20.00%
Apr-20-22 07:00AM	Enochian BioSciences Announces the Appointment of Executive Vice President of Research and Development with 25 years of Industry Experience (GlobeNewswire)
Apr-07-22 06:00AM	Enochian BioSciences Announces Appointment of Senior Vice President for Clinical Operations with 32 Years Experience at Pfizer (GlobeNewswire) -10.77%
Apr-06-22 09:07AM	Innovative Clinical Strategies to Treat HIV and Cancer Presented by Pioneering Research Scientist at the Innate Killer Summit in San Diego (PR Newswire)
Apr-05-22 06:00AM	Enochian BioSciences Inventor and Co-Founder Presents Data on Novel Clinical Approaches as the Invited, Concluding Plenary Speaker at the Innate Killer Summit (GlobeNewswire)
Mar-25-22 12:07PM	Is Enochian Biosciences, Inc. (NASDAQ:ENOB) Popular Amongst Insiders? (Simply Wall St.)
Mar-15-22 07:00AM	Enochian BioSciences and Caring Cross Announce a Partnership to Potentially Increase the Effectiveness of a CAR-T Approach for HIV Cure Currently Being Studied in Humans (GlobeNewswire)
Dec-03-21 07:00AM	Enochian BioSciences Announces Scientific Presentation at World Vaccine Conference on Promising Human and Laboratory Data to Potentially Treat Solid Tumors (GlobeNewswire) -18.64%
Oct-18-21 07:00AM	Enochian BioSciences Announces the Successful Completion of an FDA Pre-IND for a Potential Cure for HIV: The Second Pre-IND in 1 month (GlobeNewswire)
Oct-15-21 06:00PM	Scientific Advisory Board Member Resigns Due to Conflict with Responsibilities with Important Public Sector Entity (GlobeNewswire)
Oct-12-21 06:00PM	Fireside Chat with Enochian BioSciences CEO, Dr. Mark Dybul at H.C. Wainwright 2nd Annual Hepatitis B Virus (HBV) Conference (GlobeNewswire) +5.61% +6.77%
Sep-27-21 07:00AM	Enochian BioSciences Announces Its Successful Completion of FDA Pre-IND for a Potential Cure for Hepatitis B Virus Infection (GlobeNewswire)
Sep-26-21 10:42AM	Is Enochian Biosciences (NASDAQ:ENOB) Using Debt In A Risky Way? (Simply Wall St.)
Sep-13-21 07:00AM	Enochian BioSciences to Present to Investors at the H.C. Wainwright 23rd Annual Investment Conference (GlobeNewswire)
Aug-30-21 07:00AM	Distinguished Scientific and Public Health Leaders to Join Enochian BioSciences Scientific Advisory Board for Potential Inhaled Treatment and Prevention of All COVID-19 and Influenza Variants (GlobeNewswire) +11.29%
Aug-23-21 10:18AM	Distinguished Scientific and Clinical Leader to Join Enochian BioSciences Hepatitis B Cure Scientific Advisory Board (GlobeNewswire) +6.07%
Jul-20-21 07:00AM	Enochian BioSciences Names The Hon. Dr. Mark Dybul as Chief Executive Officer (GlobeNewswire)
Jul-12-21 08:37AM	Enochian Stock Is Trading Higher On FDA Acceptance of Pre-IND Request For Hepatitis B Program (Benzinga)
07:00AM	Enochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential Cure for Hepatitis B Virus Infection (GlobeNewswire)
05:37AM	Enochian Gains As FDA Agrees To Give View On Potential Cure For Hepatitis B (Investing.com)
Jun-30-21 07:00AM	Enochian BioSciences Announces Scientific Presentation of Elimination of HBV in Mice with No Evident Toxicity (GlobeNewswire)
Jun-21-21 05:31PM	Why Enochian BioSciences Was a Winner on Monday (Motley Fool)
08:03AM	Enochian BioSciences Stock Is Trading Higher After In-Licensing COVID-19, Influenza Inhaled Treatment Technology (Benzinga)
07:00AM	Enochian BioSciences Announces Acquisition of Exclusive License for Potential Pan-Coronavirus and Pan-Influenza Inhaled Treatment and Prevention Technology (GlobeNewswire)
Jun-15-21 09:05AM	Pioneering Research Institute In Los Angeles Moves One Step Closer To Finding A Cure For HIV (PR Newswire) -12.52%
Jun-14-21 03:15PM	Here's Why Enochian BioSciences Stock Skyrocketed Today (Motley Fool) +53.97%
02:53PM	Enochian BioSciences Announces $29 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (GlobeNewswire)
08:42AM	Mondays Pre-Market: Heres What You Need to Know Before the Market Opens (TipRanks)
07:00AM	Enochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential HIV Cure (GlobeNewswire)
May-12-21 04:29PM	Enochian BioSciences announces Scientific Presentation of a Person with HIV Exhibiting Controlled Blood Levels of Virus for 255 Days Following Treatment with a Novel Cellular Therapy (GlobeNewswire)
08:05AM	A Promising Approach To HIV Cell Therapy, With Exciting Preliminary Results, Was Presented Recently At The Leading Conference On Gene And Cell Therapy (PR Newswire)
Apr-30-21 03:42AM	Is Enochian Biosciences, Inc.'s (NASDAQ:ENOB) Shareholder Ownership Skewed Towards Insiders? (Simply Wall St.)
Mar-24-21 06:00PM	Seraph Research Institute and Enochian BioSciences Publish a Case Report of Complete Remission of Recurrent Glioblastoma with Innovative Therapy (GlobeNewswire) -7.65% +10.00%
Feb-22-21 05:15PM	Enochian BioSciences to Present to Investors at the H.C. Wainwright Global Life Sciences Conference (GlobeNewswire) -9.32%
Nov-01-20 09:35AM	What You Need To Know About Enochian Biosciences, Inc.'s (NASDAQ:ENOB) Investor Composition (Simply Wall St.)
Sep-10-20 12:50AM	Enochian BioSciences to Present to Investors at 22nd Annual H.C. Wainwright Global Investment Conference (GlobeNewswire)
Jul-27-20 08:00AM	Distinguished Scientific Leaders to Join Enochian BioSciences Hepatitis B Scientific Advisory Board (GlobeNewswire)
Jun-08-20 07:30AM	Enochian BioSciences Announces Its Successful Completion of FDA INTERACT Meeting for a Potential Cure for HIV (GlobeNewswire) +47.09%

Renovaro, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. The company was founded by Rene Sindlev and Serhat Gumrukcu on January 18, 2011 and is headquartered in Los Angeles, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
William Anderson Wittekind	10% Owner	Jul 17 '24	Sale	1.46	16,362	23,889	841,433	Jul 19 05:44 PM
William Anderson Wittekind	10% Owner	Jul 15 '24	Sale	1.41	21,954	30,955	875,795	Jul 17 04:32 PM
William Anderson Wittekind	10% Owner	Jul 11 '24	Sale	1.51	14,896	22,493	897,749	Jul 15 08:46 AM
William Anderson Wittekind	10% Owner	Jul 10 '24	Sale	1.51	75,000	113,250	894,645	Jul 15 08:46 AM
William Anderson Wittekind	10% Owner	Jul 09 '24	Sale	1.53	4,630	7,084	969,645	Jul 15 08:46 AM
William Anderson Wittekind	10% Owner	Jul 05 '24	Sale	1.55	60,000	93,000	974,275	Jul 08 04:50 PM
William Anderson Wittekind	10% Owner	Jul 03 '24	Sale	1.51	50,000	75,500	1,034,275	Jul 08 04:50 PM
William Anderson Wittekind	10% Owner	Jul 02 '24	Sale	1.54	34,553	53,212	1,084,275	Jul 03 07:04 PM
William Anderson Wittekind	10% Owner	Jul 01 '24	Sale	1.56	60,000	93,600	1,118,828	Jul 03 07:04 PM
William Anderson Wittekind	10% Owner	Jun 27 '24	Sale	1.50	14,671	22,006	1,178,828	Jun 27 07:37 PM
William Anderson Wittekind	10% Owner	Jun 26 '24	Sale	1.57	50,000	78,500	1,193,499	Jun 27 07:37 PM
William Anderson Wittekind	10% Owner	Jun 25 '24	Sale	1.58	20,000	31,600	1,243,499	Jun 27 07:37 PM
William Anderson Wittekind	10% Owner	Jun 14 '24	Sale	1.58	50,000	79,000	1,263,499	Jun 18 06:38 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

RENB

Renovaro Inc.

Upgrade your FINVIZ experience